Photo Besides the physical and emotional toll a disease like cancer takes, there is also the financial toll. For example, some drugs used to treat cancer are extremely expensive. For patients, there is definitely a financial aspect to managing their ...
NCCN ORP funds researchers to evaluate targeted treatment in EGFRm+ non-small cell lung cancer
"We are pleased to be working with AstraZeneca on further evaluation of osimertinib, an important targeted agent for the treatment of EGFRm+ non-small cell lung cancer. This project furthers NCCN's commitment to improving the lives of patients with ...
No comments:
Post a Comment